Coronary Artery Disease Clinical Trial
Official title:
Year-round Health Enhancing Exercise and Coronary Artery Disease: Randomized Controlled Study
A cold season involves higher cardiovascular morbidity and mortality. Several epidemiologic
studies have implicated that persons with a cardiac disease, such as coronary artery disease
(CAD) may be at higher risk for these adverse health events, but the mechanisms are not well
established. Because both exercise and cold exposure stimulates cardiac and circulatory
functions it is important to study their interaction especially among people with CAD and
whose myocardial oxygen supply and function are weakened. The study examines how recommended
health-enhancing upper and lower body exercise and warm-up in combination with cold exposure
affects cardiovascular functions of people with CAD.
The research includes randomized controlled experiments where the participants are 35-75 year
old men with CAD (CCS I-II) and recruited from the Oulu University Hospital. Each participant
undergoes four different trials in random order where the temperature (+22°C or -15°C) and
the form of exercise (brisk walking at 5.5 km/h or upper body exercise at 30 W), and warm-up
regime is varied. The used exercise, clothing and exposure resemble an ordinary wintertime
exercise event. Novel techniques are used to broadly assess cardiovascular function before,
during and in the recovery phase.
The obtained information is synthesized and translated to tailored year-round exercise
instructions for people with CAD by the research team including experts from sports sciences,
physiology, public and occupational health, clinical sciences and with complementary
knowledge in physical activity, effective interventions and cardiovascular function. The
study has broad national and international impact on the relatively passive aging population
having CAD and residing and working in a cold climate. The produced information enables
finding means to activate persons with CAD and where appropriate and safe year-round exercise
may reduce or prevent adverse health effects. Health care personnel will have an improved
possibility to prescribe physical activity programs for their clients and enabling better
instructions of healthy and safe exercise as a way to promote health.
Introduction
National and International significance of the research
According to a worldwide estimate 42% of people with coronary artery disease (CAD) are
physically inactive. There are approximately 200 000 persons in Finland with CAD, and even
more have other connected health problems (high cholesterol or blood pressure, diabetes)
further weakening their cardiac function and physical capacity and causing mortality. This
increasing ageing population are often inactive, but would benefit substantially from regular
year-round physical activity for maintaining their functional ability and independent living.
At present it is not known whether the exercise recommendation for CAD patients involves a
health risk during cold exposure as they regularly report symptoms of chest pain and
arrhythmias in the winter. Because both exercise and cold exposure stimulates cardiac and
circulatory functions precise physical activity require defining their interaction among CAD
patients whose myocardial oxygen supply and function are weakened.
Nationally and internationally the research addresses a large and special population group
living in the northern hemisphere, whose symptoms, health events and mortality are common and
provoked in the cold season. A passive lifestyle of this population is partially due to
inadequate instructions and guidance. As a result of ageing the proportion of people with CAD
will increase which emphasizes the role of prevention in reducing health care costs. The
proposed research entity forms an important part of the research program examining the direct
effect of temperature on human health in the newly established WHO Collaboration Centre in
Global change, Environment and Public Health.
Aims and hypotheses The aims are: 1) to study separate and combined effects of upper or lower
body exercise and warm-up on cardiovascular response (acute, recovery) and to 2) translate
the research information into tailored instructions for year-round physical activity.
The hypotheses are: 1) moderate level endurance exercise increase cardiovascular strain in
CAD patients in the cold compared to a warm environment, 2) upper body exercise is more
strenuous than lower body exercise in the cold, 3) warm-up exercise attenuates the cold and
exercise induced rise in BP
Participants The participants are 35-75-year old men (non-smokers) with CAD (NYHA CCS I-II),
have experienced a myocardial infarction over 3 months ago, have hypertension but no other
metabolic, cardiovascular or respiratory disease. The participants are recruited from the
Oulu University Hospital by an experienced cardiologist. The exclusion criteria are: smoking,
asthma, CCS class III-IV, diabetes, previous myocardial infarction less than 3 months ago,
chronic atrial fibrillation, claudication, unstable angina pectoris, serious complex
arrhythmias or ECG anomalies during rest.
Randomized controlled studies (n=160) The randomized controlled studies allow understanding
causality and the physiological mechanisms for the separate and combined effects of exercise
and cold on cardiovascular function in persons with CAD. Phase I (2015-16): Separate and
combined effects of cold and exercise on cardiovascular function. Each participant (n=20) is
randomly exposed to four conditions and separately to a neutral (+22°C) and cold (-15°C)
environment during rest and exercise. Phase II (2016-17): Type of exercise and warm-up on
cardiovascular function during exercise in the cold. Each participant (n=20) is randomly
exposed to four conditions involving lower (brisk walking) or upper body (arm ergometry)
exercise in the cold (-15°C) with or without warm-up exercise at +22°C. Each experimental
session lasts for 105 min (15 min baseline + 30 min exposure + 60 min recovery).
Ambient conditions The participants are exposed to both +22°C and -15°C (wind 1.4. m/s) for
30 min per experimental session in the wind tunnel of the Kastelli Research Centre. The used
cold exposure simulates conditions which occur frequently during the winter in a cold
climate. The participants are equipped with winter clothing during the experiments. The cold
exposure is largely restricted to the face which is known to increase BP by ca. 20 mmHg in
healthy subjects.
Study protocol
The experimental sessions are performed at the same time of the day for each participant.
Instructions to avoid heavy exercise or alcohol 48 h before or coffee/caffeine related
beverages 3 h prior to the experiments are given. The participants are informed of the
research, provide written consent to participate to the study and have a possibility to get
acquainted with the experimental conditions. A questionnaire inquiring of the health and
lifestyle of the participants is filled in. Following this the body composition of the
subjects is assessed by bioimpedance. A baseline blood sample is drawn. After this the
subjects are equipped with skin temperature thermistors and arm cuff (BP). ECG-electrodes are
attached both for online (12-lead) and long term (24 h) monitoring of cardiac function.
Subjects are followed in neutral conditions for 15 minutes (baseline). Continuous
beat-to-beat BP, central aortic blood pressure and flow mediated dilation is recorded before
the exposure to neutral/cold temperature and rest/exercise. For exercise in the cold the
subjects are equipped with winter clothing and enter the experimental conditions (wind
tunnel). During the exercise cardiovascular functions are followed continuously through the
real-time ECG. BP is measured every third minute at rest and during exercise. Physical strain
is assessed at 1- minute and thermal sensations at 5-minute intervals. The termination
criteria include an ST-depression of more than 2 mm, symptoms of angina, as well as a sudden
considerable change in BP. The termination of an experiment is decided by the paramedic nurse
monitoring and medical doctor supervising the experimental session. After ending the exercise
the cardiovascular functions are followed for 30 minutes at 22°C. A blood sample is taken
immediately after the exercise. Continuous and central BP is measured 3-8 minutes following
the exercise (early recovery) and after 15-20 minutes (delayed recovery). The subjects return
48-hours after the experiment for providing a blood sample which enables to examine both
immediate and delayed effects on hematological parameters (blood coagulation factors,
inflammation markers, endothelin).
Research environment and researchers
The research is coordinated by the Center for Environmental and Respiratory Health Research
(CERH) at the University of Oulu and with co-operation from the Research Unit of Internal
Medicine, Center for Machine Vision and Signal Analysis and Finnish, Institute of
Occupational Health and Finnish Defence Forces. International co-operation includes the
University of Texas Southwestern Medical Center and University of Maastricht. The experiments
are conducted in the unique thermal laboratories of Kastelli Research Centre in Oulu with
comprehensive and novel equipment for assessment of circulatory, respiratory, autonomic
nervous system function and thermal balance. The research team is multidisciplinary and
consists of experts of sports sciences, physiology, medicine, rehabilitation, and wellness
technology.
Adjunct professor Tiina Ikäheimo (former Mäkinen), Ph.D., lecturer CERH, University of Oulu;
PI of the research and with special expertise in physiology and the effects of temperature on
human health and performance. The PI has produced several original publications and reviews
and produced texts to national and international professional books (e.g. for WHO) of
cold-related health risks and recommendations for their prevention.
Research group:
Professor Heikki Huikuri, MD, Ph.D., University of Oulu and Oulu University Hospital,
Research Unit of Internal Medicine, Leader of Medical Research Center and expert in
Cardiology; Adjunct professor Antti Kiviniemi, Ph.D., senior scientist of Exercise and
Medical Physiology; Medical specialist in Cardiology, Juha Perkiömäki, MD, Ph.D.; Adjunct
professor Mikko Tulppo, Ph.D.; Adjunct professor Arto Hautala, Ph.D. Center for Machine
Vision and Signal Analysis, University of Oulu; Professor Markku Alén, MD, Ph.D., University
of Oulu, Center for Life-Course Epidemiology (CLCE); Professor Hannu Rintamäki, Ph.D. Finnish
Institute of Occupational Health; Professor Matti Mäntysaari*, MD, Ph.D., Director,
Aeromedical Centre, Finnish Defence Forces; Professor Jouni J.K. Jaakkola, MD, Ph.D.,
Director, CERH, University of Oulu; Postgraduate student Heidi Hintsala, Master in Health
Sciences (MHSc). CERH, University of Oulu; Professor emeritus Juhani Hassi, Ph.D. CERH,
University of Oulu; Doctoral student Rasmus Valtonen, CERH University of Oulu; Paramedic
nurse Miia Länsititie, CERH, University of Oulu, Project secretary Riitta Aittamaa, CERH,
University of Oulu. INTERNATIONAL: Professor Craig Crandall, Ph.D., Division of Cardiology,
Department of Internal Medicine, The University of Texas Southwestern Medical Center, USA.
Professor Wouter van Marken Lichtenbelt, Ph.D. Health, Medicine and Life Sciences, Human
Biology, Maastricht University, Netherlands.
Ethical questions
The study follows the declaration of Helsinki and the legislation, decrees and ethical
principles concerning medical research on humans in Finland. The study has been approved by
the Northern Ostrobothnia Hospital Districts Ethical Committee. The experimental tests are
performed under the monitoring of a paramedic nurse and supervision of a medical doctor.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06030596 -
SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
|
||
Completed |
NCT04080700 -
Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
|
||
Recruiting |
NCT03810599 -
Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study
|
N/A | |
Recruiting |
NCT06002932 -
Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions.
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04242134 -
Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions
|
N/A | |
Recruiting |
NCT05308719 -
Nasal Oxygen Therapy After Cardiac Surgery
|
N/A | |
Completed |
NCT04556994 -
Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients.
|
N/A | |
Recruiting |
NCT05846893 -
Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease
|
N/A | |
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Recruiting |
NCT05023629 -
STunning After Balloon Occlusion
|
N/A | |
Completed |
NCT04941560 -
Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
|
||
Completed |
NCT04006288 -
Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease
|
Phase 4 | |
Completed |
NCT01860274 -
Meshed Vein Graft Patency Trial - VEST
|
N/A | |
Recruiting |
NCT06174090 -
The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients
|
N/A | |
Completed |
NCT03968809 -
Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
|
||
Terminated |
NCT03959072 -
Cardiac Cath Lab Staff Radiation Exposure
|
||
Recruiting |
NCT05065073 -
Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography
|
Phase 4 | |
Recruiting |
NCT04566497 -
Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up.
|
N/A | |
Completed |
NCT05096442 -
Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions
|
N/A |